A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Patients With Asthma
view all Clinical Trials
The primary objective of the study is to demonstrate that dupilumab treatment improves exercise capacity in patients with moderate-to-severe asthma.
The secondary objectives of the study are:
- To demonstrate that dupilumab treatment increases physical activity of daily living in patients with moderate-to-severe asthma
- To demonstrate that dupilumab treatment improves pre- and post-exercise lung function in patients with moderate-to-severe asthma
For more information about this trial or to inquire about eligibility, email email@example.com or call 215-707-1359.